Cardiotoxicity in breast cancer patients: A single center, retrospective review
Moira Rushton(University of Ottawa), Susan Dent(Washington Hospital), Jeffrey Sulpher(BC Cancer Agency), Freya Crawley(University of Ottawa), Christopher Johnson(University of Ottawa)
Cited by 2
Related Papers
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2017|1.3k
Association of Pathologic Complete Response to Neoadjuvant Therapy in HER2-Positive Breast Cancer With Long-Term Outcomes
|JAMA Oncology|2016|375
Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy
|Canadian Journal of Cardiology|2016|234
Shared Risk Factors for Cardiovascular Disease and Cancer: Implications for Preventive Health and Clinical Care in Oncology Patients
|Canadian Journal of Cardiology|2016|173
Right heart function deteriorates in breast cancer patients undergoing anthracycline-based chemotherapy
|Echo Research and Practice|2016|56